Special Issue - Call for Papers
International Journal of Genetic Engineering
Suicide Cancer Gene Therapy

Submission deadline: 30 June 2013

Scope and purposes

Suicide gene therapy is anticancer therapy that targets tumors with toxic genes or genes encoding enzymes that produce toxic compounds, in both cell culture and animal models. Development and combination of different suicide systems will help to overcome the resistance of the cells against drugs. The development of cancer-specific gene delivery systems will reduce the toxicity and improve the effect of cancer treatment.

Topics of primary interest include, but are not limited to:
• Mechanisms inducing cancer cells deaths used in suicide gene therapy
• Suicide genes for cancer therapy
• Methods of suicide gene transfection
• Construction of cancer-specific gene delivery systems
• Treatment of cell culture and animals with vectors
• Selectivity, therapeutic efficacy and precautions in suicide cancer gene therapy.

Important Dates
Deadline for submission: 30 June 2013
Deadline for revision: 20 August 2013
Notification of final decision: 30 August 2013
Estimated Publication:

Submission
Abstracts addressing one or more of these themes/topics or further questions should be emailed to an editor by 30 June 2013.
Manuscript submissions are invited by the submission deadline. All papers will undergo a double or triple-blind peer review process.

Guest Editors
Roumiana Todorova
IBPhBME-BAS, Bulgaria
todorova@bio21.bas.bg

Manuscript submission deadline 30 June 2013

Journal Subjects

Newsletter

Just enter your email address below,we will share with you the latest information of journals published by SAP. Plus, you can easily unsubscribe at any time, and we'll never share your email address with anyone.


Our Key Strengths

Partners